Black, White Cancer Patients Now Benefit Equally From Cord Blood Therapy

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 1, 2024.

By Carole Tanzer Miller HealthDay Reporter

TUESDAY, Oct. 1, 2024 -- Blood cancer patients of all races who receive cord blood transplants are now living longer.

The finding, reported by a team led by oncologist Dr. Karen Ballen, of UVA (University of Virginia) Health, shows that a previously identified survival gap for transplant recipients has been eliminated.

"Outcomes for cord blood transplants are improving for patients of all racial and ethnic backgrounds," Ballen said in a UVA news release.

The new study looked at more than 2,600 patients with blood cancer who received umbilical cord blood transplants between 2007 and 2017.

Black, Asian, Hispanic and white recipients survived equally well, the study found.

Still, cases of "graft-versus-host" disease -- a complication of cord blood transplantation that can lead to organ damage and severe infections -- was more common in Black children.

Cord blood cells restore the patient's ability to make blood cells after such cancer treatments as high-dose chemotherapy.

Though cord blood transplants are becoming less common in the United States, researchers said cord blood remains a vital lifeline for many patients. Because it needs not be precisely matched to the recipient, it is especially helpful for patients from racial or ethnic minority groups who often struggle to find a fully matched unrelated donor.

Researchers found that matching race was less important than the total number of cord blood cells transplanted.

"The more, the better," they said.

They cited several contributors to improved survival rates. Those included improved identification of appropriate patients, newer techniques for matching patients and donors, and better antibiotics and other care.

The findings are published in the October issue of the journal Transplantation and Cellular Therapy.

Sources

  • UVA Health, news release, Sept. 30, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2024-10-02 06:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords